Citation Impact
Citing Papers
The hypothalamo‐pituitary‐adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome
1993
Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men
1998
Rising Incidence of Renal Cell Cancer in the United States
1999 Standout
The prevention of heart failure in minority communities and discrepancies in health care delivery systems
2004
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
1992
Symptoms in advanced cancer: relationship to endogenous cortisol levels
2003
Growth Hormone, Exercise, and Aging: The Future of Therapy for the Frail Elderly
1994
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment
1992
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
Physiological Significance of the Rhythmic Secretion of Hypothalamic and Pituitary Hormones
2010
Captopril
1988
Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis
2008
Cushing's syndrome
2015 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Effects of Progestin-Opposed Transdermal Estrogen Administration on Growth Hormone and Insulin-Like Growth Factor-I in Postmenopausal Women of Different Ages*
1991
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitaryadrenal insufficiency in patients with end-stage kidney disease
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
1997 StandoutNature
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type
1989
Attitudes and beliefs of african americans toward participation in medical research
1999 Standout
Reduced Efficacy of Growth Hormone-Releasing Hormone in Modulating Sleep Endocrine Activity in the Elderly
1997
Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender
1998
Robust Growth Hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH)
1991
Human Growth Hormone and Human Aging
1993
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women
2009
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Defective Hypothalamic Growth Hormone (GH)-Releasing Hormone Activity May Contribute to Declining GH Secretion with Age in Man1
1997
Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure
1996
Rationale for Fixed-Dose Combinations in the Treatment of Hypertension
2002
Fadiga relacionada ao câncer: uma revisão
2011 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
2001 Standout
Ghrelin: Structure and Function
2005 Standout
Immunologic aspects of osteoporosis
1997
Nonpeptide angiotensin II receptor antagonists
1991 Standout
Effect of Bradykinin-Receptor Blockade on the Response to Angiotensin-Converting–Enzyme Inhibitor in Normotensive and Hypertensive Subjects
1998
Impact of Gender, Menstrual Cycle Phase, and Oral Contraceptives on the Activity of the Hypothalamus-Pituitary-Adrenal Axis
1999 Standout
Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo
1993
Pharmacokinetic Optimisation of Angiotensin Converting Enzyme (ACE) Inhibitor Therapy
1992
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials
1999
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
1999 Standout
EFFECTIVE RECRUITMENT AND RETENTION OF MINORITY RESEARCH PARTICIPANTS
2005 Standout
Growth hormone secretion after the administration of GHRP‐6 or GHRH combined with GHRP‐6 does not decline in late adulthood
1995
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Sexual dimorphism of the somatotrophic axis
1998
Representation of American Blacks in Clinical Trials of New Drugs
1989
A Comparison of the Efficacy and Safety of a β-Blocker, a Calcium Channel Blocker, and a Converting Enzyme Inhibitor in Hypertensive Blacks
1990
Adverse Reactions with Angiotensin Converting Enzyme (ACE) Inhibitors
1986
Angiotensin-Converting Enzyme Inhibitors
1998
Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive Hypertensives
1998
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Rational therapies for hypertension. Is step 1 of stepped care archaic?
1987
Sex differences in growth hormone response to growth hormone-releasing hormone
1991
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
2008
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitors
1988
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
The Challenge of Minority Recruitment in Clinical Trials for AIDS
1992
Creatine and Creatinine Metabolism
2000 Standout
Neuroendocrine Control of Growth Hormone Secretion
1999
Works of H Templ being referenced
Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing factor
1990
Enhanced Growth Hormone Responses to Growth Hormone Releasing Hormone in Male Type I Diabetic Patients
1991
Effects of Sex and Age on Growth Hormone Response to Growth Hormone-Releasing Hormone in Healthy Individuals
1987
Racial differences in response to low‐dose captopril are abolished by the addition of hydrochlorothiazide.
1982
Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.
1982
Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.
1982
Abnormalities in the Hypothalamic-Pituitary-Adrenocortical Axis in Patients With Chronic Renal Failure
1987